Cytotoxicity and Proapoptotic Effects of Allium atroviolaceum Flower Extract by Modulating Cell Cycle Arrest and

Somayeh Khazaei1, Roslida Abdul Hamid1, Vasudevan Ramachandran2

  • 1Department of Biomedical Science, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia.

Insights

Allium atroviolaceum flower extract shows anticancer potential against breast cancer. It inhibits cell proliferation and induces apoptosis, offering a promising complementary treatment option.

Area of Science:

  • Phytochemistry
  • Molecular Biology
  • Oncology

Background:

  • Breast cancer remains a leading cause of cancer death globally.
  • Limited research exists on the therapeutic potential of *Allium atroviolaceum*.

Purpose of the Study:

  • To investigate the anticancer effects of *Allium atroviolaceum* flower extract on human breast cancer cell lines (MCF-7 and MDA-MB-231).
  • To elucidate the underlying mechanisms of action, including cell cycle arrest, apoptosis induction, and potential synergy with tamoxifen.

Main Methods:

  • Cell proliferation assays
  • Cell cycle analysis (flow cytometry)
  • Apoptosis assays (Annexin-V staining, microscopy)
  • Western blotting for key proteins (Cdk1, Bcl-2)
  • Liquid chromatography-mass spectrometry (LC-MS) for compound identification
  • Combination studies with tamoxifen

Main Results:

  • The extract inhibited proliferation in a time- and dose-dependent manner.
  • It induced S and G2/M phase arrest in MCF-7 cells and S phase arrest in MDA-MB-231 cells, via a p53-independent pathway involving decreased Cdk1.
  • Apoptosis was induced in both cell lines, evidenced by increased sub-G0 population, morphological changes, and Annexin-V positivity, linked to Bcl-2 downregulation and caspase activation.
  • Synergistic effects were observed when combined with tamoxifen.
  • LC-MS identified 17 major compounds in the extract.

Conclusions:

  • *Allium atroviolaceum* flower extract exhibits significant anticancer activity against breast cancer cells.
  • The extract's mechanisms involve cell cycle arrest and apoptosis induction.
  • It holds potential as a complementary therapeutic agent for breast cancer treatment.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.8K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K